|
Composition of Biotech HOLDRS
The specific share amounts for each round-lot
of 100 Biotech HOLDRS are set forth in the table below. The share amounts specified will not
change except for changes due to corporate actions or reconstitution events. Component list as of 03/22/04
| Company Name | Symbol | # of shares | % Weight |
| Affymetrix Inc | AFFX | 4.00 | 0.92% |
| Alkermes Inc | ALKS | 4.00 | 0.41% |
| Amgen Inc | AMGN | 64.48 | 27.42% |
| Applera Corporation - Applied Biosystems Group | ABI | 18.00 | 2.56% |
| Applera Corporation - Celera Genomics Group | CRA | 4.00 | 0.40% |
| Biogen Idec Inc | BIIB | 26.95 | 9.94% |
| Chiron Corporation | CHIR | 16.00 | 5.12% |
| Enzon Inc | ENZN | 3.00 | 0.33% |
| Genentech Inc | DNA | 44.00 | 32.19% |
| Genzyme Corporation | GENZ | 14.00 | 4.59% |
| Gilead Sciences Inc | GILD | 16.00 | 6.17% |
| Human Genome Sciences Inc | HGSI | 8.00 | 0.67% |
| ICOS Corp | ICOS | 4.00 | 1.07% |
| MedImmune Inc | MEDI | 15.00 | 2.55% |
| Millennium Pharmaceuticals Inc | MLNM | 12.00 | 1.48% |
| Qlt Inc | QLTI | 5.00 | 0.82% |
| Sepracor Inc | SEPR | 6.00 | 1.95% |
| Shire Pharmaceuticals Grp Plc | SHPGY | 6.83 | 1.41% |
Download the component list
|
|
Trading Units
A round lot is 100 HOLDRS. Odd lots (fewer than 100 HOLDRS) WILL NOT TRADE. |
|
Price Quotations
Quoted in dollars and fractions of a dollar per HOLDRS. Minimum “tick” is 1/16th ($0.0625). |
|
How to Purchase or Sell Biotech HOLDRS
Biotech HOLDRS may be acquired in two ways:
- through the deposit of the required number of shares of common stock of the underlying
issuers with the trustee, or
- through a cash purchase in the secondary trading market.
Biotech HOLDRS may be disposed of in two ways:
- Biotech HOLDRS may be canceled by turning them into the trustee, The Bank of New York,
and withdrawing the underlying securities, or
- Biotech HOLDRS may be sold on the secondary market.
|
|
Selling Short
Exempt from SEC Rule 10a-1(short sale rule). |
|
Life of Biotech HOLDRS Trust
The Biotech HOLDRS Trust will terminate should any of the following occur:
- The Biotech HOLDRS are delisted from The American Stock Exchange and are not listed for
trading on another national securities exchange or through Nasdaq within 5 business days
from the date of delisting.
- The Trustee resigns and no successor trustee is appointed within 60 days from the date
the trustee provides notice of its intent to resign.
- 75% of beneficial owners of outstanding Biotech HOLDRS vote to dissolve and liquidate
the trust.
- Final termination date December 31, 2039.
If a termination event occurs, the trustee will distribute the underlying securities to
owners as promptly as practicable after the termination event. |
|
Shares Outstanding
The number of outstanding Biotech HOLDRS will increase and decrease as a result of deposits and withdrawals of the underlying securities. The trust will stand ready to issue additional Biotech HOLDRS on a continuous basis when an investor deposits the required shares of common stock with the trustee. |
|
Fees and Expenses
Custody Fees: The Bank of New York, as trustee and custodian, will charge you a quarterly custody fee of $2.00 for each round-lot of 100 Biotech HOLDRS to be deducted from any cash dividend or other cash distribution on underlying securities received by the trust. The Trustee will waive any portion of the custody fee which exceeds the total cash dividends and other cash distributions received.
Issuance and Cancellation Fees: Biotech HOLDRS may be created by delivering to the trust the requisite whole shares of common stock evidencing an Biotech HOLDRS, The Bank of New York as trustee will charge an issuance fee of up to $10.00 for each round-lot of 100 Biotech HOLDRS. To cancel Biotech HOLDRS and withdraw the underlying securities, The Bank of New York as trustee will charge a cancellation fee of up to $10.00 for each round-lot of 100 Biotech HOLDRS. You can only deposit or cancel Biotech HOLDRS on an in-kind basis in round-lots of 100 Biotech HOLDRS. |
|
Minimum Customer Margin
For purchases, 50%; for short sales, 150%. |
|
Settlement Date
For trades, three New York business days. HOLDRS are in book-entry form held at The Depository
Trust Company (DTC). |
|
Trading Hours
9:30 a.m. to 4 p.m. New York time. |
|
Trading System
Specialist/Registered Options Trader. |
|
CUSIP Number
09067D 20 1 |
|
| The information in this specification sheet is not complete and may be changed. For complete details regarding rights relating to Biotech HOLDRS and rights relating to the underlying securities please refer to the prospectus. This is not an offer to sell Biotech HOLDRS and we are not soliciting offers to buy Biotech HOLDRS in any state where such offer or sale is not permitted.
“HOLDRS” and
“HOLding Company Depositary Receipts” are service
marks of Merrill Lynch & Co., Inc. |
